P520: PHASE 1/2 STUDY OF SEL24/MEN1703, A FIRST-IN-CLASS DUAL PIM/FLT3 KINASE INHIBITOR, IN PATIENTS WITH IDH1/2-MUTATED ACUTE MYELOID LEUKEMIA: THE DIAMOND-01 TRIAL.

• G. Martinelli,
• A. Santoro,
• C. Gambacorti-Passerini,
• S. Vives Polo,
• S. R. Solomon,
• S. Mukherjee,
• E. Lech-Maranda,
• M. Yair Levy,
• A. Wierzbowska,
• M. Calbacho-Robles,
• G. Marconi,
• M. Benedetta Giannini,
• I. Cano,
• L. Torres Miñana,
• E. Acuña-Cruz,
• N. Angelosanto,
• A. Galleu,
• S. Baldini,
• S. Blotta,
• F. Ravandi,
• P. Montesinos

Affiliations

G. Martinelli

1 IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”-IRST S.r.l., Meldola

A. Santoro

2 Department of Oncology, IRCCS, Humanitas Research Hospital

C. Gambacorti-Passerini

3 Department of Hematology, University of Milano-Bicocca, Milan, Italy

S. Vives Polo

4 Institut Català d’Oncologia-Hospital Germans Trias i Pujol, Badalona, Spain

S. R. Solomon

5 Northside Hospital Cancer Institute, Atlanta

S. Mukherjee

6 Taussig Cancer Institute, Cleveland Clinic, Cleveland, United States of America

E. Lech-Maranda

7 Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland

M. Yair Levy

8 Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, United States of America

A. Wierzbowska

9 Department of Hematology, Medical University of Lodz, Lodz, Poland

M. Calbacho-Robles

10 Department of Hematology, Ramón y Cajal University Hospital, Madrid, Spain

G. Marconi

11 IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” - IRST S.r.l., Meldola, Italy

M. Benedetta Giannini

11 IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” - IRST S.r.l., Meldola, Italy

I. Cano

12 Department of Hematology

L. Torres Miñana

13 Department of Hematology, La Fe University Hospital, Valencia, Spain

E. Acuña-Cruz

12 Department of Hematology

N. Angelosanto

14 13Clinical Development-Hematology, Ryvu Therapeutics, Krakow, Poland

A. Galleu

15 Hematologic Malignancies - Global Oncology TA, Menarini Group, Florence, Italy

S. Baldini

15 Hematologic Malignancies - Global Oncology TA, Menarini Group, Florence, Italy

S. Blotta

15 Hematologic Malignancies - Global Oncology TA, Menarini Group, Florence, Italy

F. Ravandi

16 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

P. Montesinos

17 La Fe University Hospital, Valencia, Spain